Shanghai Xiao Fang Pharmaceutical Co.,Ltd. (SHA:603207)

SHA:603207 Revenue

Shanghai Xiao Fang Pharmaceutical had revenue of 145.69M CNY in the quarter ending March 31, 2026, with 35.69% growth. This brings the company's revenue in the last twelve months to 504.59M, up 6.89% year-over-year. In the year 2024, Shanghai Xiao Fang Pharmaceutical had annual revenue of 474.58M with 0.57% growth.

• Revenue (ttm): 504.59M
• Revenue Growth: +6.89%
• P/S Ratio: 8.37
• Revenue / Employee: 1.25M
• Employees: 404
• Market Cap: 4.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	474.58M	2.71M	0.57%
Dec 31, 2023	471.87M	14.98M	3.28%
Dec 31, 2022	456.89M	55.12M	13.72%
Dec 31, 2021	401.77M	40.54M	11.22%
Dec 31, 2020	361.23M	21.62M	6.37%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 28, 2026

Data Sources Report a data error